A trial of a unique formulation of ibuprofen treatment for treating severe acute respiratory distress syndrome (ARDS) has launched.
Researchers have found a common 'immune signature' in many of the sickest COVID-19 patients which could help guide treatment.
To mark Clinical Trials Day 2020, we highlight some of our research trials in response to COVID-19.
Researchers will be commencing a COVID-19 project to help clinical staff more effectively triage patients with COVID-19.
A new treatment is being tested at Guy’s and St Thomas’ NHS Foundation Trust with the support of King’s College London research.
A prototype ventilator, developed by King’s College London and the University of Oxford, has been shortlisted for the next stage of testing.
Guy’s and St Thomas’ Charity launches air pollution programme to reduce health impact on the most vulnerable in our communities.
Newly funded projects across our partnership will explore how social circumstance and health interact for people with long-term conditions.
New report finds that London children travelling to primary schools are five times more exposed to air pollution than at any other time.
Our researchers have found that a potential treatment for peanut allergy provides some protection but does not cure an allergic patient.
Scientists have found that children with severe eczema infected with a specific bacterium, are at higher risk of developing a food allergy.
A new trial which could revolutionise the way chronic back pain is treated on the NHS has been launched by Guy’s and St Thomas’.